Informations générales (source: ClinicalTrials.gov)

NCT03271333 Statut inconnu
Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma and Analysis of Associated Factors. (SCLERO-PID)
Observational
  • Pneumopathie infectieuse
  • Sclérodermie systémique
  • Sclérodermie diffuse
University Hospital, Lille (Voir sur ClinicalTrials)
avril 2018
avril 2025
05 avril 2025
Diffuse infiltrating pneumonia (DIP) is a severe complication of systemic sclerosis and one of the leading cause of death in this condition. The main objective of this study is to prospectively describe the evolution of DIP overtime and to find prognosis factors.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AH-HP, Hôpital Saint Antoine - 75571 - Paris 12 - France En recrutement Contact (sur clinicalTrials)
Hôpital Claude Huriez, CHU - Lille - France David Launay, MD,PHD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- systemic sclerosis

- Diffuse Infiltrating Pneumonia


- infection

- other lung diseases

- non French native